{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T09:45:16Z","timestamp":1791884716676,"version":"4.3.4"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2018,4,27]],"date-time":"2018-04-27T00:00:00Z","timestamp":1524787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2018,4,27]],"date-time":"2018-04-27T00:00:00Z","timestamp":1524787200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Death Dis"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Osteolysis is an osteolytic lesion featured by enhanced osteoclast formation and potent bone erosion. Lacking of effective regimen for treatment of the pathological process highlights the importance of identifying agents that can suppress the differentiation and function of osteoclast. Artemether is a natural compound derived from Artemisia annua L. and it is popularized for the treatment of malaria. In present study, we demonstrated that artemether could suppress RANKL-induced osteoclastogenesis and expression of osteoclast marker genes such as tartrate-resistant acid phosphatase, cathepsin K, matrix metalloproteinase 9, nuclear factor of activated T-cell cytoplasmic 1, and dendritic cell-specific transmembrane protein. It inhibited the osteoclastic bone resorption in a dose-dependent manner in vitro. Furthermore, artemether attenuated RANKL-induced MAPKs (ERK, JNK, p-38) activity. In addition, we have showed that artemether was able to mitigate bone erosion in a\u00a0murine model of LPS-induced inflammatory bone loss. Taken together, these findings suggest that artemether reduces inflammatory bone loss via inhibition of MAPKs activation during osteoclast differentiation, and it might be a potential candidate for the treatment of osteoclast-related disorders.<\/jats:p>","DOI":"10.1038\/s41419-018-0540-y","type":"journal-article","created":{"date-parts":[[2018,4,27]],"date-time":"2018-04-27T07:58:49Z","timestamp":1524815929000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":75,"title":["Artemether attenuates LPS-induced inflammatory bone loss by inhibiting osteoclastogenesis and bone resorption via suppression of MAPK signaling pathway"],"prefix":"10.1038","volume":"9","author":[{"given":"Haobo","family":"Wu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bin","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaopeng","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chenhe","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiahong","family":"Meng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yute","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiang","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhongli","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shigui","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,4,27]]},"reference":[{"key":"540_CR1","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1002\/jbmr.2710","volume":"31","author":"X Zhu","year":"2016","unstructured":"Zhu, X. et al. Alexidine dihydrochloride attenuates osteoclast formation and bone resorption and protects against LPS-induced osteolysis. J. Bone Miner. Res. 31, 560\u2013572 (2016).","journal-title":"J. Bone Miner. Res."},{"key":"540_CR2","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1177\/1753425912451779","volume":"19","author":"J Gallo","year":"2013","unstructured":"Gallo, J., Goodman, S. B., Konttinen, Y. T. & Raska, M. Particle disease: biologic mechanisms of periprosthetic osteolysis in total hip arthroplasty. Innate Immun. 19, 213\u2013224 (2013).","journal-title":"Innate Immun."},{"key":"540_CR3","first-page":"115","volume":"21","author":"SC Manolagas","year":"2000","unstructured":"Manolagas, S. C. Birth and death of bone cells: basic regulatory mechanisms and implications for the pathogenesis and treatment of osteoporosis. Endocr. Rev. 21, 115\u2013137 (2000).","journal-title":"Endocr. Rev."},{"key":"540_CR4","doi-asserted-by":"publisher","first-page":"2082","DOI":"10.1359\/jbmr.2001.16.11.2082","volume":"16","author":"Y Bi","year":"2001","unstructured":"Bi, Y. et al. Adherent endotoxin on orthopedic wear particles stimulates cytokine production and osteoclast differentiation. J. Bone Miner. Res. 16, 2082\u20132091 (2001).","journal-title":"J. Bone Miner. Res."},{"key":"540_CR5","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1016\/j.bone.2015.07.023","volume":"81","author":"KJ Kim","year":"2015","unstructured":"Kim, K. J. et al. Decursin inhibits osteoclastogenesis by downregulating NFATc1 and blocking fusion of pre-osteoclasts. Bone 81, 208\u2013216 (2015).","journal-title":"Bone"},{"key":"540_CR6","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.bone.2016.02.020","volume":"86","author":"F Loi","year":"2016","unstructured":"Loi, F. et al. Inflammation, fracture and bone repair. Bone 86, 119\u2013130 (2016).","journal-title":"Bone"},{"key":"540_CR7","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1182\/blood-2009-08-237628","volume":"115","author":"FC Cackowski","year":"2010","unstructured":"Cackowski, F. C. et al. Osteoclasts are important for bone angiogenesis. Blood 115, 140\u2013149 (2010).","journal-title":"Blood"},{"key":"540_CR8","doi-asserted-by":"publisher","first-page":"1092","DOI":"10.1096\/fj.14-262055","volume":"29","author":"H Guan","year":"2015","unstructured":"Guan, H., Zhao, L., Cao, H., Chen, A. & Xiao, J. Epoxyeicosanoids suppress osteoclastogenesis and prevent ovariectomy-induced bone loss. FASEB J. 29, 1092\u20131101 (2015).","journal-title":"FASEB J."},{"key":"540_CR9","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1196\/annals.1346.020","volume":"1068","author":"S Tanaka","year":"2006","unstructured":"Tanaka, S. et al. Molecular mechanism of the life and death of the osteoclast. Ann. N. Y. Acad. Sci. 1068, 180\u2013186 (2006).","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"540_CR10","first-page":"204","volume":"8","author":"MP Yavropoulou","year":"2008","unstructured":"Yavropoulou, M. P. & Yovos, J. G. Osteoclastogenesis--current knowledge and future perspectives. J. Musculoskelet. Neuron. Interact. 8, 204\u2013216 (2008).","journal-title":"J. Musculoskelet. Neuron. Interact."},{"key":"540_CR11","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/S0092-8674(00)81569-X","volume":"93","author":"DL Lacey","year":"1998","unstructured":"Lacey, D. L. et al. Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation. Cell 93, 165\u2013176 (1998).","journal-title":"Cell"},{"key":"540_CR12","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1038\/nature01658","volume":"423","author":"WJ Boyle","year":"2003","unstructured":"Boyle, W. J., Simonet, W. S. & Lacey, D. L. Osteoclast differentiation and activation. Nature 423, 337\u2013342 (2003).","journal-title":"Nature"},{"key":"540_CR13","doi-asserted-by":"publisher","first-page":"E13","DOI":"10.1111\/j.1749-6632.2011.06373.x","volume":"1240","author":"T Nakashima","year":"2011","unstructured":"Nakashima, T. & Takayanagi, H. New regulation mechanisms of osteoclast differentiation. Ann. N. Y. Acad. Sci. 1240, E13\u2013E18 (2011).","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"540_CR14","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1097\/01.blo.0000238813.95035.1b","volume":"454","author":"PE Purdue","year":"2007","unstructured":"Purdue, P. E., Koulouvaris, P., Potter, H. G., Nestor, B. J. & Sculco, T. P. The cellular and molecular biology of periprosthetic osteolysis. Clin. Orthop. Relat. Res. 454, 251\u2013261 (2007).","journal-title":"Clin. Orthop. Relat. Res."},{"key":"540_CR15","doi-asserted-by":"publisher","first-page":"4855","DOI":"10.1096\/fj.201700316R","volume":"31","author":"X Chen","year":"2017","unstructured":"Chen, X. et al. Matrine prevents bone loss in ovariectomized mice by inhibiting RANKL-induced osteoclastogenesis. FASEB J. 31, 4855\u20134865 (2017).","journal-title":"FASEB J."},{"key":"540_CR16","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1111\/bph.12463","volume":"171","author":"ZJ Zhai","year":"2014","unstructured":"Zhai, Z. J. et al. Andrographolide suppresses RANKL-induced osteoclastogenesis in vitro and prevents inflammatory bone loss in vivo. Br. J. Pharmacol. 171, 663\u2013675 (2014).","journal-title":"Br. J. Pharmacol."},{"key":"540_CR17","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.1126\/science.3887571","volume":"228","author":"DL Klayman","year":"1985","unstructured":"Klayman, D. L. Qinghaosu (artemisinin): an antimalarial drug from China. Science 228, 1049\u20131055 (1985).","journal-title":"Science"},{"key":"540_CR18","doi-asserted-by":"publisher","first-page":"526","DOI":"10.4269\/ajtmh.16-0780","volume":"97","author":"R Mwaiswelo","year":"2017","unstructured":"Mwaiswelo, R. et al. Sustained high cure rate of artemether-lumefantrine against uncomplicated plasmodium falciparum malaria after 8 years of its wide-scale use in Bagamoyo District, Tanzania. Am. J. Trop. Med. Hyg. 97, 526\u2013532 (2017).","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"540_CR19","doi-asserted-by":"publisher","first-page":"6426","DOI":"10.1007\/s12035-015-9543-1","volume":"53","author":"UP Okorji","year":"2016","unstructured":"Okorji, U. P., Velagapudi, R., El-Bakoush, A., Fiebich, B. L. & Olajide, O. A. Antimalarial drug artemether inhibits neuroinflammation in BV2 microglia through nrf2-dependent mechanisms. Mol. Neurobiol. 53, 6426\u20136443 (2016).","journal-title":"Mol. Neurobiol."},{"key":"540_CR20","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1080\/08923970500418786","volume":"27","author":"S Cuzzocrea","year":"2005","unstructured":"Cuzzocrea, S., Saadat, F., Di Paola, R. & Mirshafiey, A. Artemether: a new therapeutic strategy in experimental rheumatoid arthritis. Immunopharmacol. Immunotoxicol. 27, 615\u2013630 (2005).","journal-title":"Immunopharmacol. Immunotoxicol."},{"key":"540_CR21","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1002\/jcb.21167","volume":"101","author":"H Hotokezaka","year":"2007","unstructured":"Hotokezaka, H. et al. Molecular analysis of RANKL-independent cell fusion of osteoclast-like cells induced by TNF-alpha, lipopolysaccharide, or peptidoglycan. J. Cell Biochem. 101, 122\u2013134 (2007).","journal-title":"J. Cell Biochem."},{"key":"540_CR22","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1007\/s00109-004-0612-6","volume":"83","author":"H Takayanagi","year":"2005","unstructured":"Takayanagi, H. Mechanistic insight into osteoclast differentiation in osteoimmunology. J. Mol. Med. 83, 170\u2013179 (2005).","journal-title":"J. Mol. Med."},{"key":"540_CR23","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1038\/nri2062","volume":"7","author":"H Takayanagi","year":"2007","unstructured":"Takayanagi, H. Osteoimmunology: shared mechanisms and crosstalk between the immune and bone systems. Nat. Rev. Immunol. 7, 292\u2013304 (2007).","journal-title":"Nat. Rev. Immunol."},{"key":"540_CR24","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1038\/35085597","volume":"412","author":"C Wang","year":"2001","unstructured":"Wang, C. et al. TAK1 is a ubiquitin-dependent kinase of MKK and IKK. Nature 412, 346\u2013351 (2001).","journal-title":"Nature"},{"key":"540_CR25","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1016\/S1534-5807(02)00369-6","volume":"3","author":"H Takayanagi","year":"2002","unstructured":"Takayanagi, H. et al. Induction and activation of the transcription factor NFATc1 (NFAT2) integrate RANKL signaling in terminal differentiation of osteoclasts. Dev. Cell 3, 889\u2013901 (2002).","journal-title":"Dev. Cell"},{"key":"540_CR26","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1097\/BLO.0b013e31804b4147","volume":"460","author":"G Holt","year":"2007","unstructured":"Holt, G., Murnaghan, C., Reilly, J. & Meek, R. M. The biology of aseptic osteolysis. Clin. Orthop. Relat. Res. 460, 240\u2013252 (2007).","journal-title":"Clin. Orthop. Relat. Res."},{"key":"540_CR27","doi-asserted-by":"publisher","first-page":"1497","DOI":"10.1002\/jor.23292","volume":"34","author":"MK Wasko","year":"2016","unstructured":"Wasko, M. K. & Goodman, S. B. Emperor\u2019s new clothes: Is particle disease really infected particle disease? J. Orthop. Res. 34, 1497\u20131504 (2016).","journal-title":"J. Orthop. Res."},{"key":"540_CR28","doi-asserted-by":"publisher","first-page":"1434","DOI":"10.2106\/00004623-199910000-00008","volume":"81","author":"H Segawa","year":"1999","unstructured":"Segawa, H., Tsukayama, D. T., Kyle, R. F., Becker, D. A. & Gustilo, R. B. Infection after total knee arthroplasty. A retrospective study of the treatment of eighty-one infections. J. Bone Joint Surg. Am. 81, 1434\u20131445 (1999).","journal-title":"J. Bone Joint Surg. Am."},{"key":"540_CR29","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1302\/0301-620X.84B5.11775","volume":"84","author":"B Skoglund","year":"2002","unstructured":"Skoglund, B., Larsson, L. & Aspenberg, P. A. Bone-resorptive effects of endotoxin-contaminated high-density polyethylene particles spontaneously eliminated in vivo. Bone Jt. J. 84, 767\u2013773 (2002).","journal-title":"Bone Jt. J."},{"key":"540_CR30","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1016\/j.bbrc.2007.06.023","volume":"360","author":"S Islam","year":"2007","unstructured":"Islam, S. et al. Bacterial lipopolysaccharide induces osteoclast formation in RAW 264.7 macrophage cells. Biochem. Biophys. Res. Commun. 360, 346\u2013351 (2007).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"540_CR31","doi-asserted-by":"crossref","first-page":"2371","DOI":"10.1128\/iai.64.7.2371-2380.1996","volume":"64","author":"SP Nair","year":"1996","unstructured":"Nair, S. P. et al. Bacterially induced bone destruction: mechanisms and misconceptions. Infect. Immun. 64, 2371\u20132380 (1996).","journal-title":"Infect. Immun."},{"key":"540_CR32","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1097\/01.blo.0000224050.94248.38","volume":"451","author":"JL Nalepka","year":"2006","unstructured":"Nalepka, J. L. et al. Lipopolysaccharide found in aseptic loosening of patients with inflammatory arthritis. Clin. Orthop. Relat. Res. 451, 229\u2013235 (2006).","journal-title":"Clin. Orthop. Relat. Res."},{"key":"540_CR33","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1002\/jbm.b.30150","volume":"72","author":"EM Greenfield","year":"2005","unstructured":"Greenfield, E. M. et al. Does endotoxin contribute to aseptic loosening of orthopedic implants? J. Biomed. Mater. Res. B Appl. Biomater. 72, 179\u2013185 (2005).","journal-title":"J. Biomed. Mater. Res. B Appl. Biomater."},{"key":"540_CR34","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1002\/jbm.b.31247","volume":"90","author":"MF Maitz","year":"2009","unstructured":"Maitz, M. F., Teichmann, J., Sperling, C. & Werner, C. Surface endotoxin contamination and hemocompatibility evaluation of materials. J. Biomed. Mater. Res. B Appl. Biomater. 90, 18\u201325 (2009).","journal-title":"J. Biomed. Mater. Res. B Appl. Biomater."},{"key":"540_CR35","doi-asserted-by":"publisher","first-page":"e01516","DOI":"10.1128\/AAC.01516-17","volume":"61","author":"SA Rasmussen","year":"2017","unstructured":"Rasmussen, S. A. et al. Changing antimalarial drug sensitivities in Uganda. Antimicrob. Agents Chemother. 61, e01516\u2013e01517 (2017).","journal-title":"Antimicrob. Agents Chemother."},{"key":"540_CR36","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.bcp.2014.10.019","volume":"93","author":"C Wu","year":"2015","unstructured":"Wu, C. et al. Myricetin prevents titanium particle-induced osteolysis in vivo and inhibits RANKL-induced osteoclastogenesis in vitro. Biochem. Pharmacol. 93, 59\u201371 (2015).","journal-title":"Biochem. Pharmacol."},{"key":"540_CR37","doi-asserted-by":"publisher","first-page":"5050","DOI":"10.1210\/endo.142.12.8536","volume":"142","author":"S Khosla","year":"2001","unstructured":"Khosla, S. Minireview: the OPG\/RANKL\/RANK system. Endocrinology 142, 5050\u20135055 (2001).","journal-title":"Endocrinology"},{"key":"540_CR38","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1016\/j.bone.2015.02.017","volume":"75","author":"FL Yuan","year":"2015","unstructured":"Yuan, F. L. et al. Leonurine hydrochloride inhibits osteoclastogenesis and prevents osteoporosis associated with estrogen deficiency by inhibiting the NF-kappaB and PI3K\/Akt signaling pathways. Bone 75, 128\u2013137 (2015).","journal-title":"Bone"},{"key":"540_CR39","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1111\/j.1399-0004.2010.01619.x","volume":"80","author":"DA Stevenson","year":"2011","unstructured":"Stevenson, D. A. et al. Bone resorption in syndromes of the Ras\/MAPK pathway. Clin. Genet. 80, 566\u2013573 (2011).","journal-title":"Clin. Genet."},{"key":"540_CR40","first-page":"153","volume":"22","author":"G Pearson","year":"2001","unstructured":"Pearson, G. et al. Mitogen-activated protein (MAP) kinase pathways: regulation and physiological functions. Endocr. Rev. 22, 153\u2013183 (2001).","journal-title":"Endocr. Rev."},{"issue":"Suppl 1","key":"540_CR41","doi-asserted-by":"publisher","first-page":"i86","DOI":"10.1136\/ard.2009.119396","volume":"69","author":"EF Wagner","year":"2010","unstructured":"Wagner, E. F. Bone development and inflammatory disease is regulated by AP-1 (Fos\/Jun). Ann. Rheum. Dis. 69(Suppl 1), i86\u2013i88 (2010).","journal-title":"Ann. Rheum. Dis."},{"key":"540_CR42","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1196\/annals.1402.071","volume":"1116","author":"H Takayanagi","year":"2007","unstructured":"Takayanagi, H. The role of NFAT in osteoclast formation. Ann. N. Y. Acad. Sci. 1116, 227\u2013237 (2007).","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"540_CR43","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1210\/me.2007-0237","volume":"22","author":"K Kim","year":"2008","unstructured":"Kim, K., Lee, S. H., Ha Kim, J., Choi, Y. & Kim, N. NFATc1 induces osteoclast fusion via upregulation of Atp6v0d2 and the dendritic cell-specific transmembrane protein (DC-STAMP). Mol. Endocrinol. 22, 176\u2013185 (2008).","journal-title":"Mol. Endocrinol."},{"key":"540_CR44","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1359\/jbmr.2000.15.1.103","volume":"15","author":"NZ Angel","year":"2000","unstructured":"Angel, N. Z. et al. Transgenic mice overexpressing tartrate-resistant acid phosphatase exhibit an increased rate of bone turnover. J. Bone Miner. Res. 15, 103\u2013110 (2000).","journal-title":"J. Bone Miner. Res."},{"key":"540_CR45","doi-asserted-by":"publisher","first-page":"1236","DOI":"10.1126\/science.273.5279.1236","volume":"273","author":"BD Gelb","year":"1996","unstructured":"Gelb, B. D., Shi, G. P., Chapman, H. A. & Desnick, R. J. Pycnodysostosis, a lysosomal disease caused by cathepsin K deficiency. Science 273, 1236\u20131238 (1996).","journal-title":"Science"},{"key":"540_CR46","doi-asserted-by":"publisher","first-page":"2152","DOI":"10.1002\/art.21951","volume":"54","author":"HA Kim","year":"2006","unstructured":"Kim, H. A. et al. The catabolic pathway mediated by Toll-like receptors in human osteoarthritic chondrocytes. Arthritis Rheum. 54, 2152\u20132163 (2006).","journal-title":"Arthritis Rheum."},{"key":"540_CR47","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1002\/jcp.10041","volume":"190","author":"K Suda","year":"2002","unstructured":"Suda, K., Woo, J. T., Takami, M., Sexton, P. M. & Nagai, K. Lipopolysaccharide supports survival and fusion of preosteoclasts independent of TNF-alpha, IL-1, and RANKL. J. Cell Physiol. 190, 101\u2013108 (2002).","journal-title":"J. Cell Physiol."},{"key":"540_CR48","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1016\/j.actbio.2016.11.022","volume":"48","author":"X Hu","year":"2017","unstructured":"Hu, X. et al. Theaflavin-3,3\u2019-digallate represses osteoclastogenesis and prevents wear debris-induced osteolysis via suppression of ERK pathway. Acta Biomater. 48, 479\u2013488 (2017).","journal-title":"Acta Biomater."}],"container-title":["Cell Death &amp; Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41419-018-0540-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-018-0540-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-018-0540-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,6]],"date-time":"2024-07-06T10:12:08Z","timestamp":1720260728000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41419-018-0540-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,4,27]]},"references-count":48,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2018,5]]}},"alternative-id":["540"],"URL":"https:\/\/doi.org\/10.1038\/s41419-018-0540-y","relation":{},"ISSN":["2041-4889"],"issn-type":[{"value":"2041-4889","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,4,27]]},"assertion":[{"value":"9 December 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 March 2018","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 March 2018","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 April 2018","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"498"}}